These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effectiveness of transcutaneous electrical nerve stimulation and interferential current in primary dysmenorrhea. Tugay N, Akbayrak T, Demirtürk F, Karakaya IC, Kocaacar O, Tugay U, Karakaya MG, Demirtürk F. Pain Med; 2007; 8(4):295-300. PubMed ID: 17610451 [Abstract] [Full Text] [Related]
5. Treatment of dysmenorrhoea with a new TENS device (OVA). Schiøtz HA, Jettestad M, Al-Heeti D. J Obstet Gynaecol; 2007 Oct; 27(7):726-8. PubMed ID: 17999304 [Abstract] [Full Text] [Related]
8. Intrauterine pressure changes during dysmenorrhea therapy. Smith RP, Powell JR. Am J Obstet Gynecol; 1982 Jun 01; 143(3):286-92. PubMed ID: 6805330 [Abstract] [Full Text] [Related]
9. A rationale for the treatment of dysmenorrhea. Csapo AI. J Reprod Med; 1980 Oct 01; 25(4 Suppl):213-21. PubMed ID: 7001020 [Abstract] [Full Text] [Related]
10. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies. Daniels S, Robbins J, West CR, Nemeth MA. Clin Ther; 2009 Jun 01; 31(6):1192-208. PubMed ID: 19695387 [Abstract] [Full Text] [Related]
11. Treatment of primary and secondary dysmenorrhea with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study. Wildemeersch D, Schacht E, Wildemeersch P. Eur J Contracept Reprod Health Care; 2001 Dec 01; 6(4):192-8. PubMed ID: 11848648 [Abstract] [Full Text] [Related]
13. Primary dysmenorrhea: advances in pathogenesis and management. Dawood MY. Obstet Gynecol; 2006 Aug 01; 108(2):428-41. PubMed ID: 16880317 [Abstract] [Full Text] [Related]
14. Dysmenorrhea. French L. Am Fam Physician; 2005 Jan 15; 71(2):285-91. PubMed ID: 15686299 [Abstract] [Full Text] [Related]
15. Transcutaneous electrical nerve stimulation (TENS) as a relief for dysmenorrhea. Kaplan B, Peled Y, Pardo J, Rabinerson D, Hirsh M, Ovadia J, Neri A. Clin Exp Obstet Gynecol; 1994 Jan 15; 21(2):87-90. PubMed ID: 8070122 [Abstract] [Full Text] [Related]
16. Effect of short-term, low-dose treatment with tamoxifen in patients with primary dysmenorrhea. Pierzyński P, Swiatecka J, Oczeretko E, Laudański P, Batra S, Laudański T. Gynecol Endocrinol; 2006 Dec 15; 22(12):698-703. PubMed ID: 17162713 [Abstract] [Full Text] [Related]
17. Managing the pain of primary and secondary dysmenorrhoea. Jones AE. Nurs Times; 2006 Dec 15; 100(10):40-3. PubMed ID: 15045780 [Abstract] [Full Text] [Related]
18. Dysmenorrhoea. Proctor M, Farquhar C. Clin Evid; 2003 Jun 15; (9):1994-2013. PubMed ID: 15366171 [No Abstract] [Full Text] [Related]
19. The role of transcutaneous electrical nerve stimulation for menstrual pain relief: A randomized control trial. McLagan B, Dexheimer J, Strock N, Goldstein S, Guzman S, Erceg D, Schroeder ET. Womens Health (Lond); 2024 Jun 15; 20():17455057241266455. PubMed ID: 39066557 [Abstract] [Full Text] [Related]
20. Clinical evaluation of a new model of a transcutaneous electrical nerve stimulation device for the management of primary dysmenorrhea. Kaplan B, Rabinerson D, Lurie S, Peled Y, Royburt M, Neri A. Gynecol Obstet Invest; 1997 Jun 15; 44(4):255-9. PubMed ID: 9415524 [Abstract] [Full Text] [Related] Page: [Next] [New Search]